EORTC/MSG definitions

More documents

Recommendations

Info

Who uses the EORTC/MSG definitions? Clinical trials Diagnostic tests
How valuable do you consider the EORTC/MSG definitions? 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% very usefulquite usefuldon't knownot very useful quite useless
Page 1 and 2: Update: New EORTC /MSG criteria for
Page 3 and 4: EORTC-IFICG & NIAID-MSG 2002
Page 5: Strengths
Page 9 and 10: Strengths EORTC/MSG definitions •
Page 11 and 12: • Why revise? • The process •
Page 13 and 14: Problems INAPPROPRIATE USE • appl
Page 15 and 16: Patient groups at risk of developin
Page 17 and 18: Goal of adapting definitions proven
Page 19 and 20: Answer Host factor neutropenic + Cl
Page 21 and 22: ICAAC 43 Chicago 2003 a) the need f
Page 23 and 24: ICAAC 43 Chicago 2003 - working par
Page 25 and 26: QuickTime and a TIFF (Uncompressed)
Page 27 and 28: Plan B Microbiological Criteria.doc
Page 29 and 30: Round 1 E-mail E-mail E-mail E-mail
Page 31 and 32: Definitions II process Round 1 Roun
Page 33 and 34: QuickTime and a TIFF (Uncompressed)
Page 35 and 36: No change
Page 37 and 38: Defining invasive fungal disease Ho
Page 39 and 40: First change
Page 41 and 42: What’s in a name? Invasive Fungal
Page 43 and 44: Definitions I - Possible invasive f
Page 45 and 46: Invasive fungal disease - Definitio
Page 47 and 48: Definitions II - Possible invasive
Page 49 and 50: Definitions - Host factors neutrope
Page 51 and 52: Definitions - Host factors neutrope
Page 53 and 54: Patients at risk of developing IFD
Page 55 and 56: Fourth change
Page 57 and 58:
Definitions - Clinical features Low
Page 59 and 60:
Definitions - Clinical features Low
Page 61 and 62:
Specific pulmonary infiltrates on C
Page 63 and 64:
Fifth change
Page 65 and 66:
Definitions - Mycology Culture of m
Page 67 and 68:
Definitions - Mycology Culture of m
Page 69 and 70:
Slicing the cake
Page 71 and 72:
Separating the chaff from the wheat
Page 73 and 74:
Separating the chaff from the wheat
Page 75 and 76:
Do you apply EORTC/MSG definitions
Page 77 and 78:
Scheme for managing high-risk patie
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
EORTC/MSG definitions - aspergillos
Page 85 and 86:
For example.. CID 2007:44 (15 May)
Page 87 and 88:
Table 2. Favorable overall response
Page 89 and 90:
At risk population proven probable
Page 91 and 92:
Eligible for future studies proven
show all

EORTC/MSG definitions

Create successful ePaper yourself

Delete template?

Save as template?